NLRP3 and psoriasis: More importantly, our in vivo studies demonstrated that amounts of LPA species in psoriasis lesions were elevated and that suppressing LPA5 activity could attenuate NLRP3 upregulation in psoriasis lesions, particularly in infiltrated macrophages.